Navigation Links
Reportlinker Adds Cancer Vaccines: Measuring Market Potential
Date:11/10/2009

NEW YORK, Nov. 10 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Cancer Vaccines: Measuring Market Potential

http://www.reportlinker.com/p0158343/Cancer-Vaccines-Measuring-Market-Potential.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

This brand new report published in October 2004 provides an overview of the emerging market for cancer vaccines and measures their potential impact on a number of cancer markets.

Vaccine product candidates are discussed within the context of the disease areas they are attempting to penetrate and include: melanoma, prostate cancer, colorectal cancer, lung cancer, breast cancer, and pancreatic cancer.

There are currently over twenty Phase III trials ongoing for various indications and new approvals may come as early as 2005. The value of the market for cancer vaccines has the potential to reach $6 billion by 2010.

This report is designed to provide the information, insight and analysis key to an understanding of how cancer vaccines will impact the biotech and pharmaceutical marketplace. Those in the field of cancer therapy and cancer vaccines will want to read this report in order to better understand where and how vaccines will make a difference in future cancer therapy.

This 232-page report:

  • Gauges the potential of key vaccine products nearing commercialization.
  • Analyzes the results of key clinical trials as a means of determining future success in the market.
  • Forecasts financial growth of the cancer vaccine market through 2010.
  • Assesses the competition from cytotoxics and other biologics in six key cancer markets.
  • Provides valuable data concerning patient populations, survival rates, and global epidemiology
  • Identifies and discusses trends and issues that will have a significant impact on the cancer vaccine market.
  • Profiles the leading companies in the field and provides valuable information and analysis concerning their lead vaccine candidates.

To order this report:

Cancer Vaccines: Measuring Market Potential

http://www.reportlinker.com/p0158343/Cancer-Vaccines-Measuring-Market-Potential.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

More market research reports here!

    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
2. Reportlinker Adds Worldwide Optical, Transmission TEM, and Scanning SEM Electron Microscope Market Shares, Strategies, and Forecasts, 2009 to 2015
3. Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment
4. Reportlinker Adds Bioinformatics and Computational Biology: Bottlenecks and Options
5. Reportlinker Adds Global Top 10 Biotechnology Companies -- Industry, Financial and SWOT Analysis
6. Reportlinker Adds Stem Cell Therapeutics Markets Report
7. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
8. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
9. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
10. Reportlinker Adds Membrane Bioreactors Report
11. Reportlinker Adds Nanoporous Materials Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., ... a Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. ... best practices and how Proscia improves lab economics and realizes an increase in ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks Associates ... will speak at the TMA 2017 Annual Meeting , October 11 ... in the residential home security market and how smart safety and security ... Parks Associates: ... "The residential security ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in an ... on RFD-TV. , With global population estimates nearing ten billion people by 2050, ... a growing nation. At the same time, many of our valuable resources are becoming ...
Breaking Biology Technology:
(Date:4/24/2017)... , April 24, 2017 Janice ... partner with  Identity Strategy Partners, LLP (IdSP) , ... or without President Trump,s March 6, 2017 ... Entry , refugee vetting can be instilled with greater ... (Right now, all refugee applications are suspended by ...
(Date:4/17/2017)... April 17, 2017 NXT-ID, Inc. (NASDAQ: ... the filing of its 2016 Annual Report on Form 10-K on ... ... is available in the Investor Relations section of the Company,s website ... SEC,s website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... PALM BEACH GARDENS, Fla. , April 11, ... biometric identity management and secure authentication solutions, today ... million contract by Intelligence Advanced Research Projects Activity ... technologies for IARPA,s Thor program. "Innovation ... the onset and IARPA,s Thor program will allow ...
Breaking Biology News(10 mins):